Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Update on US review of Fasenra in nasal polyps
Investegate announcements from AstraZeneca PLC, Update on US review of Fasenra in nasal polyps
Source: investegate.co.uk
📰 Emerging Endotypes News
Emerging Endotypes News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Emerging Endotypes. Real-time updates on events, politics, business and more.
First patients dosed in Phase III trials evaluating Fasenra in hypereosinophilic syndrome, eosinophilic esophagitis and eosinophilic granulomatosis
Search jobs 16-Dec-2020 First patients dosed in Phase III trials evaluating Fasenra in hypereosinophilic syndrome, eosinophilic esophagitis and eosinophilic granulomatosis with polyangiitis New clinical trial also announced for Fasenra in eosinophilic gastritis/eosinophilic gastroenteritis The first patients have been dosed in Fasenra (benralizumab) Phase III trials in three rare eosinophilic diseases: hypereosinophilic syndrome (HES), eosinop...
Source: pharmiweb.com